My research goal is to define epigenomic mechanisms that are cancer drivers, and exploit this understanding in diagnostic settings and targeted therapies. Specifically, we focus on understanding how epigenomic events disrupt transcription in solid tumors, notably prostate and breast cancer. To achieve this research goal my group undertakes interdisciplinary approaches. Thus we aim to conceive, design, and interpret experiments that are undertaken both in the wet lab, in Eppendorf tubes, and in the dry lab, at the computer command line.
- Dean’s Innovative Research Award, 2019
- Clinical Sciences Translational Research Fellow, 2011
- Royal Society Travel Award, 2001
- Pfizer Travel Award, 2000
- Gillard Exchange Fellowship, 2000
- View all honors